2m 2m 2m 2m 2m 2m 2m
Avricore Health (AVCRF)
OTC
$0.0008-$0.02 (-96.80%)
Price as of Sep 03, 2026- $5.4MMarket Cap
- -97.95%1-Year Change
- Diagnostics & ResearchIndustry
Avricore Health (AVCRF)
$0.0008-$0.02 (-96.80%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.0008
$0.04
$0.0008
1-Year Range
$0.0008
$0.07
$0.0008
Latest Close$0.0008
Change
-$0.02 (-3,021.10%)
Volume22,083
Market Cap$5.4M
Shares Outstanding101.3M
P/E (TTM)-5.29
Diluted EPS (TTM)-$0.01
Enterprise Value$4.2M
Information as of 09/03/2026
Company Profile
Avricore Health Inc.
https://avricore.com$5.4M
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Diagnostics & Research
700 ? 1199 West Hastings Street, Vancouver, BC, Canada, V6E 3T5
778 968 1176Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Key Executives
- Rodger Seccombe
- Kiriaki Smith
- Will Seccombe
Current Ownership Distribution
- Other101.3M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)